High Outlier
DEA Schedule CII
Strength
25.9 mg/1
Manufacturer
Neos Therapeutics Brands, LLCNDC
70165030030
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
4/1/2026
Active Ingredients
METHYLPHENIDATEApproval Type
New Drug (NDA)
FDA Application
NDA205489On Market Since
6/20/2017
Pharmacological Classes
Central Nervous System Stimulant
Central Nervous System Stimulation
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
EXCEDRIN EXTRA STRENGTH GELTAB
Brand
00067202124•Haleon US Holdings LLC
$0.1205
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200020•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200024•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200033•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200050•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200077•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200091•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE GELTAB
Brand
00067203520•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE CAPLET
Brand
00067203924•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE CAPLET
Brand
00067203933•Haleon US Holdings LLC
$0.1338
per EA